Navigation Links
Clear Acne 3x Faster With ClarityMD Acne System, Newly Unveiled at the American Academy of Dermatology Annual Meeting
Date:2/28/2013

WESTLAKE VILLAGE, Calif., Feb. 28, 2013 /PRNewswire/ -- Envy Medical Inc., expands its skin care offerings beyond the celebrated Lumixyl® System with the launch of the ClarityMD™ Acne Solution—in what could be the most exciting advancement in acne treatment in decades—at the American Academy of Dermatology Annual Meeting on March 1 in Miami.

The ClarityMD Acne System combines the power of the Deep Pore Cleanser and Clarifying Gel in a two-step system that's clinically proven to significantly heal acne within days. In fact, a recent study shows that ClarityMD clears acne three times faster than the leading over-the-counter and topical acne prescription products on the market today.

Envy Medical, also the makers of the popular SilkPeel® MD, has revolutionized the way acne is treated with their new patent-pending PCX™ Technology available only in ClarityMD, which features solubilized bakuchiol and bisabolol that together help salicylic acid attack acne at its source while helping to regulate pore-clogging oil production and to reduce inflammation.

The ClarityMD Acne System will be unveiled at booth #369 on the AAD Exhibit floor. Dr. Felipe Jimenez , Envy's Chief Scientific Officer, led the development of this new technology and will be on hand to introduce the system and debut the exciting results from a new clinical study.

Accordingly to the study, the ClarityMD Acne Solution was tested on 25 volunteers that used the Deep Pore Cleanser and Clarifying Gel twice daily over six weeks. After seven days volunteers enjoyed an average 59% reduction in inflammatory acne lesions and a 14% reduction in non-inflammatory acne lesions. After six weeks, 99% of inflammatory and 56% of non-inflammatory acne lesions had been cleared. Plus, unlike benzoyl peroxide- or salicylic acid-based acne products, the results showed that ClarityMD does not dry out skin or cause irritation, redness or peeling.

"Even the best acne products can take up to six weeks to work. However, unpleasant side effects from these regimens, including dryness and irritation, often cause patients to stop using the products prior to getting relief from acne. With the launch of ClarityMD, patients can now rapidly clear their acne in a safe and effective manner," says Curtis A. Cluff , CEO of Envy Medical Inc.

The ClarityMD Acne System will be sold through dermatology, cosmetic surgery and medical spa physicians throughout the United States. The suggested retail price is $49.95 for the two-step system that includes a 6 fl oz Deep Pore Cleanser and a 1 fl oz Clarifying Gel. For more information go to www.claritymdacne.com or contact info@envymedical.com

The American Academy of Dermatology's 71st Annual Meeting will be held in Miami Beach, March 1-5, 2013, at the Miami Beach Convention Center.

ABOUT ENVY MEDICAL—Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion™ for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is available in Envy's Lumixyl Topical Brightening System as well as in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photodamage. More information can be found at www.envymedical.com.


'/>"/>
SOURCE Envy Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
2. TechPrecision Corporation Receives Nuclear Order for $860,000
3. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
4. Nuclear Medicine Information Systems and BioDose rebrand and relaunch as ec2 Software Solutions
5. Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits
6. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
7. Prescription Eyewear Limited Extends Clear Leadership Position in Growing European Online Optical Market With Acquisition of Nordic Leader LensOn
8. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
9. ClearCanvas Platform Powers Tumor Imaging Metrics Core Measurements
10. The NeuViz 64 Multi-slice CT Scanner from Neusoft Medical Systems Receives FDA Clearance
11. Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):